Eficácia e segurança da terapia com células derivadas do tecido adiposo no tratamento de úlceras crônicas de extremidades: uma revisão sistemática e metanálise de ensaios clínicos randomizados e controlados
Efficacy and safety of adipose tissue-derived cell therapy in the treatment of chronic extremity ulcers: a systematic review and meta-analysis of randomized controlled trials
Edenilson de Souza Teixeira; Vanessa Ellen Silva Carmo; Hideki Zimermann Kamitani; Johnnatas Mikael Lopes; Sydney Correia Leão; Carlos Alberto de Lima Botelho Filho; Pedro Pereira Tenório
Resumo
Palavras-chave
Abstract
Keywords
Referências
1 Järbrink K, Ni G, Sönnergren H, et al. The humanistic and economic burden of chronic wounds: a protocol for a systematic review. Syst Rev. 2017;6(1):15.
2 Oliveira GMD, Gomes Filho AO, Silva JGMD, et al. Bacterial cellulose biomaterials for the treatment of lower limb ulcers. Rev Col Bras Cir. 2023;50:e20233536.
3 Dantas JS, Silva ACDOE, Augusto FDS, et al. Health-related quality of life in people with chronic wounds and associated factors. Texto Contexto Enferm. 2022;31:e20220010.
4 Duscher D, Barrera J, Wong VW, et al. Stem cells in wound healing: the future of regenerative medicine? A mini-review. Gerontology. 2016;62(2):216-25.
5 Elsharkawi M, Ghoneim B, O’Sullivan M, et al. Role of adipose derived stem cells in patients with diabetic foot ulcers: systematic review and meta-analysis of randomised controlled trials. Int J Low Extrem Wounds. 2025;24(3):542-9.
6 Martinengo L, Olsson M, Bajpai R, et al. Prevalence of chronic wounds in the general population: systematic review and meta-analysis of observational studies. Ann Epidemiol. 2019;29:8-15.
7 Gentile P, Garcovich S. Advances in regenerative stem cell therapy in androgenic alopecia and hair loss: wnt pathway, growth-factor, and mesenchymal stem cell signaling impact analysis on cell growth and hair follicle development. Cells. 2019;8(5):466.
8 Safari B, Aghazadeh M, Davaran S, Roshangar L. Exosome-loaded hydrogels: a new cell-free therapeutic approach for skin regeneration. Eur J Pharm Biopharm. 2022;171:50-9.
9 Carstens MH, Zelaya M, Calero D, Rivera C, Correa D. Adipose-derived stromal vascular fraction (SVF) cells for the treatment of non-reconstructable peripheral vascular disease in patients with critical limb ischemia: A 6-year follow-up showing durable effects. Stem Cell Res. 2020;49:102071.
10 Bacakova L, Zarubova J, Travnickova M, et al. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells – a review. Biotechnol Adv. 2018;36(4):1111-26.
11 Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
12 Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097.
13 Higgins JPT, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
14 Dettori JR, Norvell DC, Chapman JR. Fixed-Effect vs Random-Effects Models for Meta-Analysis: 3 Points to Consider. Global Spine J. 2022;12(7):1624-6.
15 Nordic Cochrane Centre. Review Manager 5.4. Copenhagen: Nordic Cochrane Centre; 2020.
16 Shao SC, Kuo LT, Huang YT, Lai PC, Chi CC. Using Grading of Recommendations Assessment, Development, and Evaluation (GRADE) to rate the certainty of evidence of study outcomes from systematic reviews: a quick tutorial. Zhonghua Pifuke Yixue Zazhi. 2023;41(1):3.
17 Zollino I, Campioni D, Sibilla MG, Tessari M, Malagoni AM, Zamboni P. A phase II randomized clinical trial for the treatment of recalcitrant chronic leg ulcers using centrifuged adipose tissue containing progenitor cells. Cytotherapy. 2019;21(2):200-11.
18 Namgoong S, Yoon IJ, Han SK, Son JW, Kim J. A pilot study comparing a micronized adipose tissue niche versus standard wound care for treatment of neuropathic diabetic foot ulcers. J Clin Med. 2022;11(19):5887.
19 Lonardi R, Leone N, Gennai S, Trevisi Borsari G, Covic T, Silingardi R. Autologous micro-fragmented adipose tissue for the treatment of diabetic foot minor amputations: a randomized controlled single-center clinical trial (MiFrAADiF). Stem Cell Res Ther. 2019;10(1):223.
20 Tanios E, Ahmed TM, Shafik EA, et al. Efficacy of adipose-derived stromal vascular fraction cells in the management of chronic ulcers: a randomized clinical trial. Regen Med. 2021;16(11):975-88.
21 Smith OJ, Leigh R, Kanapathy M, et al. Fat grafting and platelet‐rich plasma for the treatment of diabetic foot ulcers: a feasibility‐randomised controlled trial. Int Wound J. 2020;17(6):1578-94.
22 Uzun E, Guney A, Gonen Z, et al. Intralesional allogeneic adipose-derived stem cells application in chronic diabetic foot ulcer: phase I/2 safety study. Foot Ankle Surg. 2021;27(6):636-42.
23 Moon KC, Suh HS, Kim KB, et al. Potential of allogeneic adipose-derived stem cell–hydrogel complex for treating diabetic foot ulcers. Diabetes. 2019;68(4):837-46.
24 Del Papa N, Zaccara E, Maglione W, Di Luca G, Andracco R, Vitali C. Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomised controlled study. Ann Rheum Dis. 2018;77:122.
25 Thamm OC, Eschborn J, Zimmermann L, et al. Sublesional fat grafting leads to a temporary improvement of wound healing in chronic leg ulcers: a prospective, randomised clinical trial. Wound Repair Regen. 2023;31(5):663-70.
26 Alinda MD, Christopher PM, Listiawan MY, et al. The efficacy of topical adipose mesenchymal stem cell-conditioned medium versus framycetin gauze dressing in chronic plantar ulcer of leprosy: A randomized controlled trial. Indian J Dermatol Venereol Leprol. 2023;89(5):656-64.
27 Han SK, Kim HR, Kim WK. The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: a pilot study. Wound Repair Regen. 2010;18(4):342-8.
28 Huang YZ, Gou M, Da LC, Zhang WQ, Xie HQ. Mesenchymal stem cells for chronic wound healing: current status of preclinical and clinical studies. Tissue Eng Part B Rev. 2020;26(6):555-70.
29 Gentile P, Garcovich S. Systematic review: adipose-derived mesenchymal stem cells, platelet-rich plasma and biomaterials as new regenerative strategies in chronic skin wounds and soft tissue defects. Int J Mol Sci. 2021;22(4):1538.
30 Wei JT, He T, Shen K, Xu ZG, Han JT, Yang XK. Adipose stem cell-derived exosomes in the treatment of wound healing in preclinical animal models: a meta-analysis. Burns Trauma. 2024;12:tkae025.
31 Mazini L, Rochette L, Admou B, Amal S, Malka G. Hopes and Limits of Adipose-Derived Stem Cells (ADSCs) and Mesenchymal Stem Cells (MSCs) in Wound Healing. Int J Mol Sci. 2020;21(4):1306.
32 Papadopoulos KS, Piperi C, Korkolopoulou P. Clinical Applications of Adipose-Derived Stem Cell (ADSC) Exosomes in Tissue Regeneration. Int J Mol Sci. 2024;25(11):5916.
33 Wang Y, Cheng L, Zhao H, et al. The Therapeutic Role of ADSC-EVs in Skin Regeneration. Front Med (Lausanne). 2022;9:858824.
34 Xiao S, Liu Z, Yao Y, Wei ZR, Wang D, Deng C. Diabetic Human Adipose-Derived Stem Cells Accelerate Pressure Ulcer Healing by Inducing Angiogenesis and Neurogenesis. Stem Cells Dev. 2019;28(5):319-28.
35 Alexandrushkina N, Nimiritsky P, Eremichev R, et al. Cell Sheets from Adipose Tissue MSC Induce Healing of Pressure Ulcer and Prevent Fibrosis via Trigger Effects on Granulation Tissue Growth and Vascularization. Int J Mol Sci. 2020;21(15):5567.
36 Sterne JAC, Sutton AJ, Ioannidis JPA, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.
37 Lazzarini PA, Cramb SM, Golledge J, Morton JI, Magliano DJ, Van Netten JJ. Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century. Diabetologia. 2023;66(2):267-87.
38 Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: physiopathology and treatment. World J Diabetes. 2015;6(3):432-44.
39 Russo A, Condello V, Madonna V, Guerriero M, Zorzi C. Autologous and micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis. J Exp Orthop. 2017;4(1):33.
40 Carter MJ, Fife CE. Counting the cost of cellular and/or tissue-based products in diabetic foot ulcers: is there a justifiable price limit per square centimeter? Adv Wound Care (New Rochelle). 2025;14(4):181-7.
41 Nherera LM, Banerjee J. Cost effectiveness analysis for commonly used human cell and tissue products in the management of diabetic foot ulcers. Health Sci Rep. 2024;7(3):e1991.
Submetido em:
28/01/2026
Aceito em:
05/06/2026
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email